GeoVax Labs Inc. Issues Letter to Shareholders
ATLANTA, April 27 /PRNewswire/ -- GeoVax Labs, Inc. (OTC Bulletin Board:GOVX.ob - News), a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines, has issued a letter to its shareholders and has added a question and answer section to its website. To view the shareholder letter in its entirety, please follow this link to the Company's website: www.geovax.com.